Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01610804

Enrollment

Registered

2012-06-04

Start date

2011-04-30

Completion date

2012-05-31

Last updated

2012-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroidal Thickness

Brief summary

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT). Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients with initial diagnosis of CSCR and no treatment so far

Exclusion criteria

* Therapy (drugs/laser) due to CSCR

Countries

Germany

Outcome results